These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

76 related items for PubMed ID: 1421615

  • 21. In vivo distribution and antitumor activity of doxorubicin-loaded N-isopropylacrylamide-co-methacrylic acid coated mesoporous silica nanoparticles and safety evaluation.
    Chen Y, Yang W, Chang B, Hu H, Fang X, Sha X.
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):406-12. PubMed ID: 23816639
    [Abstract] [Full Text] [Related]

  • 22. Pharmacokinetics and pharmacodynamics of doxorubicin in patients with small cell lung cancer.
    Piscitelli SC, Rodvold KA, Rushing DA, Tewksbury DA.
    Clin Pharmacol Ther; 1993 May; 53(5):555-61. PubMed ID: 8387903
    [Abstract] [Full Text] [Related]

  • 23. Pharmacokinetics of iododoxorubicin in the rat, dog, and monkey.
    Edwards DM, Marrari P, Efthymiopoulos C, Basileo G, Fraier D, Pianezzola E, Strolin-Benedetti M.
    Drug Metab Dispos; 1991 May; 19(5):938-45. PubMed ID: 1686240
    [Abstract] [Full Text] [Related]

  • 24. Doxorubicin and doxorubicinol: intra- and inter-individual variations of pharmacokinetic parameters.
    Jacquet JM, Bressolle F, Galtier M, Bourrier M, Donadio D, Jourdan J, Rossi JF.
    Cancer Chemother Pharmacol; 1990 May; 27(3):219-25. PubMed ID: 2265458
    [Abstract] [Full Text] [Related]

  • 25. Pharmacokinetics of weekly low dose doxorubicin.
    Frenay M, Milano G, Renee N, Pons D, Khater R, François E, Thyss A, Namer M.
    Eur J Cancer Clin Oncol; 1989 Feb; 25(2):191-5. PubMed ID: 2702975
    [Abstract] [Full Text] [Related]

  • 26. Comparison of pharmacokinetics, tissue distribution and pharmacodynamics of liposomal and free doxorubicin in tumour-bearing mice following intratumoral injection.
    Ren S, Li C, Dai Y, Li N, Wang X, Tian F, Zhou S, Qiu Z, Lu Y, Zhao D, Chen X, Chen D.
    J Pharm Pharmacol; 2014 Sep; 66(9):1231-9. PubMed ID: 24716458
    [Abstract] [Full Text] [Related]

  • 27. Investigation of hepatobiliary disposition of doxorubicin following intrahepatic delivery of different dosage forms.
    Lilienberg E, Ebeling Barbier C, Nyman R, Hedeland M, Bondesson U, Axén N, Lennernäs H.
    Mol Pharm; 2014 Jan 06; 11(1):131-44. PubMed ID: 24171458
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Doxorubicin, ifosfamide, and dacarbazine (AID) with mesna uroprotection for advanced untreated sarcoma: a phase I study.
    Elias AD, Antman KH.
    Cancer Treat Rep; 1986 Jul 06; 70(7):827-33. PubMed ID: 3087617
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Possibilities to increase the effectiveness of doxorubicin in cancer cells killing.
    Hanušová V, Boušová I, Skálová L.
    Drug Metab Rev; 2011 Nov 06; 43(4):540-57. PubMed ID: 21942373
    [Abstract] [Full Text] [Related]

  • 36. Prochlorperazine as a doxorubicin-efflux blocker: phase I clinical and pharmacokinetics studies.
    Sridhar KS, Krishan A, Samy TS, Sauerteig A, Wellham LL, McPhee G, Duncan RC, Anac SY, Ardalan B, Benedetto PW.
    Cancer Chemother Pharmacol; 1993 Nov 06; 31(6):423-30. PubMed ID: 8453681
    [Abstract] [Full Text] [Related]

  • 37. Pharmacology of N-benzyladriamycin-14-valerate in the rat.
    Sweatman TW, Seshadri R, Israel M.
    Cancer Chemother Pharmacol; 1999 Nov 06; 43(5):419-26. PubMed ID: 10100599
    [Abstract] [Full Text] [Related]

  • 38. Pharmacokinetics of low-dose doxorubicin and metabolites in patients with AIDS-related Kaposi sarcoma.
    Joerger M, Huitema AD, Meenhorst PL, Schellens JH, Beijnen JH.
    Cancer Chemother Pharmacol; 2005 May 06; 55(5):488-96. PubMed ID: 15726371
    [Abstract] [Full Text] [Related]

  • 39. Pharmacokinetic evaluation of intraperitoneal doxorubicin in rats.
    Nagai K, Nogami S, Egusa H, Konishi H.
    Pharmazie; 2014 Feb 06; 69(2):125-7. PubMed ID: 24640601
    [Abstract] [Full Text] [Related]

  • 40. Effect of sublethal liver injury on doxorubicin metabolism.
    August DA, Halter S, Brenner DE.
    Clin Cancer Res; 1995 Mar 06; 1(3):351-8. PubMed ID: 9815991
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 4.